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Rare cause of post-squalene disorder of
cholesterol biosynthesis
Acetyl-CoA units are converted to
mevalonate by a series of reactions.
Mevalonate is formed on squalene
and then lanosterol. Lanosterol is
converted by two different
pathways, either with the creation
of 7-dehydrocholesterol, or
desmosterol with the creation of
cholesterol.
Errors of cholesterol biosynthesis
represent a heterogeneous group of
metabolic disorders that is
c h a r a c t e r i z e d b y m u l t i p l e
dysmorphic features underlining an
important role for cholesterol in
human embryogenes i s and
development.
The differential diagnosis of
atypical findings on the skin in
newborn may be the result of
d i s o r d e r o f c h o l e s t e r o l
biosynthesis. It may be also
associated with various dysmorphic
features or anomalies including
multiple anomalies of congenital
and internal organs and skeletal
abnormalities. Some of the post-
squalene disorders may point to
atypical findings on the skin in the
form of psoriatic eruptions,
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Abstract Errors of cholesterol
b i o s y n t h e s i s r e p r e s e n t a
heterogeneous group of metabolic
disorders. The aim of the authors of
this article is to present a case of a
patient with typical symptoms of a
rare post-squalene disorder of
cholesterol biosynthesis, its
diagnostics and progress in
neonatal period. The differential
diagnosis of a typical findings on
the skin with spontaneous
r e g r e s s i o n i c h t y o s i f o r m
erythroderma, craniofac ia l
dysmorphic features, anomalies of
organs or skeletal abnormalities in
a newborn may also be the result of
a d i so rde r o f cho les t e ro l
biosynthesis. The final diagnosis is
definitely confirmed by DNA
analysis. Prognosis depends on the
different enzyme defects of
cholesterol biosynthesis pathway,
but typically on the post-squalene
pathway.
Cholesterol is an important
substance that plays a significant
role in membrane structure, as well
as being the precursor for the
synthesis of the steroid hormones
and bile acids. Cholesterol
synthesis occurs in the cytoplasm
and microsomes from the two-
carbon acetate group of acetyl
coenzyme A (acetyl-CoA). The
biosynthesis of cholesterol
consists of several reactions.
1
Case report
The authors present the case of a female newborn
with pathological findings. Growth retardation of
long bones and polyhydramnion in the 32 week of
gestation were found during pregnancy. The patient
nd
was born by caesarean section in the 39 week of
gestation. Birth weight was 3360 grams and birth
length was 41 centimeters (corresponding to the 3
percentile).Apgar score was 10/10.
Her parents were healthy. In childhood, mother was
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cholesterol 0.66 mmol/l [Normal value < 3.4 mmol/l],
apolipoprotein A-I 0.69 g/l [normal value 1.08 - 2.25
g/l] and apolipoprotein B 0.47 g/l [normal value 0.50
1.30 g/l]. After first week of life total cholesterol was at
the level of 4.55 mmol/l. However, a mild and isolated
hypertriacylglycerolaemia persists in the lipid profile at
1.85 mmol/l [normal value < 1,30 mmol/l]. Complete
blood count and CRPwere within normal levels.
UV spectrometry and gas chromatography/mass
spectrometry (GC/MS) were negative. Cytogenetic
examination confirmed female karyotype, 46, XX.
Molecular genetic examination detected heterozygous
mutation (c.386G> A) in the EBP gene
(EBP - emopamil-binding protein) encoding delta (8)-
delta(7) sterol isomerase, thereby confirming the
diagnosis of chondrodysplasia punctata type 2
(CDPX2).
Skeletal dysplasias form a heterogeneous group of
inherited diseases of the skeleton. They may arise from
disorders of metabolism of cartilage, bone or ligament.
According to the international classification of
osteochondrodysplasias they are divided into three
main groups, including 1. defects of long and flat bones
or axial skeleton, 2. pathological development of
cartilage and fibrous components of the skeleton, and 3.
idiopathic osteolysis.
Chondrodysplasia punctata type 2 (CDPX2) belongs to
the first group and is a clinically and genetically
heterogeneous disorder. It is characterized by
punctiform calcification of the bones. It is an X-linked
dominant genetic disorder also known as Conradi-
syndrome. Brachytelephalangic
form of chondrodysplasia punctata was described by
Sheffield in 1976. It is X-linked recessive form, which
is caused by mutation in arylsulfatase E gene (ARSE).
Zizka et al., 1998, reported two cases of rhizomelic
chondrodysplasia punctata with distinctive phenotype
and autosomal recessive type of inheritance.
Chondrodysplasia punctata type 2 is rare form of
skeletal dysplasia. Its incidence and also prevalence is
unknown. In all, approximately 50 cases have been
reported in literature.
Molecular analysis can confirm the diagnosis. To date,
there have been descriptions in literature which
described 46 various mutations. In our case, the
mutation of (c.386G>A) in the EBP
gene encoding delta(8)-delta(7) sterol izomerase was










coxae congenita. Mother's height in adulthood was
158 centimeters. Her 3-year-old elder sister was
healthy.
At birth, short stature, asymmetrical shortening of
the femora and humeri, flat face, saddle nose, coarse
and sparse hair, wide neck with marked torticollis,
transversal lines on the palms with marked ulnar
deviation and right talipes equinovarus were all
noted. Large hyperkeratotic irregular linear scales on
erythrodermic background were found on skin (Fig
1). Cutaneous lesion reminded of a collodion baby.
Fig 1
Radiography showed asymmetric shortening of the
long bones and expanded metaphyseal femur, tibia
and epiphyseal stippling of long bones (Fig 2) and the
cartilage of ribs.
Fig 2
Orthopedic examination confirmed right talipes
equinovarus with good mobility and right hip with
limited abduction, with possible dysplastic changes
and tendency for right torticollis.
Ultrasonography detected mild dilatation of renal
pelvis of the left side. Echocardiography confirmed
small ventricular septal defect and foramen ovale
appertum. Ophthalmologic examination excluded
cataract and auditory emissions were without
pathological findings. Neurological examination and
ultrasonography of the brain were negative.
Laboratory tests revealed reduced total cholesterol at
1,87 mmol/l [normal value 2,30 4,8 mmol/l] on the
second day of life.The level of HDL cholesterol was
0,26 mmol/l [normal value < 1,68 mmol/l], LDL
Newborn with typical skin lesions of Conradi H nermann
Radiographic image of epiphyseal stippling of long bones
ű
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Published cases in the literature have mostly been
females, but X-linked dominant chondrodysplasia
punctata may be inherited as a lethal form in
hemizygous males.
Other EBP mutations have been reported with no
evidence of correlation between phenotype of patients
with CDPX2. There are even some studies that present
marked variation in expressivity within the same
mutation and the same family means, which signals that
the phenotypic effect of a given mutation cannot be
predicted, even within a family. This strong intra-
familial variation is of paramount importance when
predicting the prognosis of a particular CDPX2 patient
and providing genetic counseling to CDPX2 families.
After a complete investigation of the patient's mother, it
was found in our case that it was an isolated occurrence
of mutation.
Prenatal diagnosis is available by finding mutations on
amniocentesis or chorionic villus sampling. Kelley in
1999 found growth retardation, asymmetry of bone
and polyhydramnios in fetuses in the second and third
trimesters of gestations. In our case a significant growth
retardation of long bones and polyhydramnios was
detected prenatally in our patient by ultrasonography in
the 32 week of gestation.
syndrome, is an X chromosomal
dominant disorder of cholesterol biosynthesis. In
neonatal age, it is necessary to think about this post-
squalene disorder of cholesterol biosynthesis within the
differential diagnosis of atypical findings on the skin,
craniofacial dysmorphic features and asymmetric
shortening of extremities or skeletal abnormalities and
organ anomalies.
In affected patients, the analysis of sterols in plasma can
lead to the detection of accumulation of 8-
dehydrocholesterol or cholest-8(9)-enol. Radiographic
changes show typical epiphyseal stippling of long
bones, which can lead to diagnosis, but it is definitely
confirmed by molecular genetic analysis.
Clinical findings were dominated by reversible skin
lesions with spontaneous regression ichthyosiform
Erythroderma, with the creation of systematic skin
atrophy in infancy. The prognosis of patients with
Conradi- -Happle syndrome is good.
Psychomotor development is usually normal,
sometimes with mild retardation. Patients need
dermatologic care and regular application of
emollients. Limb asymmetry and scoliosis can lead to
premature arthritis, which would require the
cooperation with orthopedists.
Prenatal detection of significant shortening of long







Chondrodyslasia punctata type 2, known as Conradi-
Hűnermann-Happle
Hűnermann
Confirmed mutation leads to a premature stop codon
of amino acid chain and then to a formation of
truncated protein EBP with altered function
confirming the diagnosis of CDPX2. Due to the of
the gene's mutation, a defect of delta (8) - delta (7)
sterol isomerase is formed, which is an enzyme that
plays an important role in the last steps of post-
squalene pathway of cholesterol biosynthesis. In this
case it was an isolated occurrence in the family.
Dysmorphic features represent skin defects
including linear or whorled atrophic and pigmentary
lesions, striated hyperkeratosis, coarse lusterless hair
and alopecia, cataract and craniofacial defects. On
admission of the patient in our case, large
hyperkeratotic irregular linear scales dominated on
the skin. Skin findings improved spontaneously in
the neonatal period. Currently, the 1-year-old girl's
dry skin and follicular atrophoderma especially on
the head persist.
The baby in our case was born at term but Rakheja et
al., 2007, reported the case of a premature female
newborn with rhizomesoacromeli
Chondrodysplasia punctata type 2 is one of the six
post-squalene disorders of cholesterol biosynthesis.
Herman et al., 2003 described other disorders: the
S m i t h - L e m l i - O p i t z s y n d r o m e ( S L O S ) ,
Desmosterolosis, CHILD (congenital hemidysplasia
with ichthyosiform erythroderma and limb defects
(syndrome) syndrome, Lathosterolosis and HEM
(hydrops-ectopic calcification-moth-eaten skeletal
dysplasia) syndrome. Among the most common
disorders of cholesterol biosynthesis in the care of
some European metabologists is SLOS.
Gas chromatography/mass spectrometry (GC/MS)
analysis revealed markedly elevated levels of 8-
cholest-8(9)-en- -ol and helped to identify somatic
mosaicism in a clinically unaffected men.
Sutphen et al., 1995, reported of a male patient with
X-linked dominant chondrodysplasia punctata and
with a 47, XXY karyotype, who died at the age of 31
years due to restricted pulmonary disease secondary
to severe kyphoscoliosis. Derry et al., 1999,
suggested that the presence of toxic sterol
intermediates may be associated with lethality in
boys and assumed that some features of CDPX2
phenotype form direct defect of abnormal
cholesterol biosynthesis. The exact mechanism by
which the disrupted enzyme function leads to









of upper and lower extremities and craniofacial
dysmorphism. Diagnosis of CDPX2 was made based
on elevated cholest-8(9)-en-3β-ol in serum and
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